TY - BOOK PY - 2019 DA - 2019// TI - World malaria report 2019 PB - World Health Organization CY - Geneva ID - ref1 ER - TY - STD TI - National Malaria Control Programme (NMCP) KNBoSK, and ICF International. Kenya Malaria Indicator Survey 2015. Nairobi, Kenya, and Rockville, Maryland, USA: NMCP, KNBS, and ICF International; 2016. ID - ref2 ER - TY - JOUR AU - Otienoburu, S. D. AU - Maiga-Ascofare, O. AU - Schramm, B. AU - Jullien, V. AU - Jones, J. J. AU - Zolia, Y. M. PY - 2016 DA - 2016// TI - Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or Artemether−lumefantrine in Liberia JO - Malar J. VL - 15 ID - Otienoburu2016 ER - TY - JOUR AU - Ogutu, B. R. AU - Onyango, K. O. AU - Koskei, N. AU - Omondi, E. K. AU - Ongecha, J. M. AU - Otieno, G. A. PY - 2014 DA - 2014// TI - Efficacy and safety of Artemether−lumefantrine and Dihydroartemisinin−piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study JO - Malar J. VL - 13 ID - Ogutu2014 ER - TY - BOOK PY - 2018 DA - 2018// TI - Artemisinin and artemisinin-based combination therapy resistance PB - World Health Organization CY - Geneva ID - ref5 ER - TY - JOUR AU - Talundzic, E. AU - Ravishankar, S. AU - Kelley, J. AU - Patel, D. AU - Plucinski, M. AU - Schmedes, S. PY - 2018 DA - 2018// TI - Next-Generation Sequencing and Bioinformatics Protocol for Malaria Drug Resistance Marker Surveillance JO - Antimicrob Agents Chemother VL - 62 ID - Talundzic2018 ER - TY - JOUR AU - Picot, S. AU - Olliaro, P. AU - Monbrison, F. AU - Bienvenu, A. L. AU - Price, R. N. AU - Ringwald, P. PY - 2009 DA - 2009// TI - A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria JO - Malar J. VL - 8 ID - Picot2009 ER - TY - JOUR AU - Mohammed, A. AU - Ndaro, A. AU - Kalinga, A. AU - Manjurano, A. AU - Mosha, J. F. AU - Mosha, D. F. PY - 2013 DA - 2013// TI - Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania JO - Malar J. VL - 12 ID - Mohammed2013 ER - TY - JOUR AU - Duraisingh, M. T. AU - Jones, P. AU - Sambou, I. AU - Seidlein, L. AU - Pinder, M. AU - Warhurst, D. C. PY - 2000 DA - 2000// TI - The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin JO - Mol Biochem Parasitol VL - 108 ID - Duraisingh2000 ER - TY - JOUR AU - Reed, M. B. AU - Saliba, K. J. AU - Caruana, S. R. AU - Kirk, K. AU - Cowman, A. F. PY - 2000 DA - 2000// TI - Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum JO - Nature VL - 403 ID - Reed2000 ER - TY - JOUR AU - Duraisingh, M. T. AU - Roper, C. AU - Walliker, D. AU - Warhurst, D. C. PY - 2000 DA - 2000// TI - Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum JO - Mol Microbiol VL - 36 ID - Duraisingh2000 ER - TY - JOUR AU - Mwai, L. AU - Kiara, S. M. AU - Abdirahman, A. AU - Pole, L. AU - Rippert, A. AU - Diriye, A. PY - 2009 DA - 2009// TI - In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1 JO - Antimicrob Agents Chemother VL - 53 ID - Mwai2009 ER - TY - JOUR AU - Tumwebaze, P. AU - Conrad, M. D. AU - Walakira, A. AU - LeClair, N. AU - Byaruhanga, O. AU - Nakazibwe, C. PY - 2015 DA - 2015// TI - Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children JO - Antimicrob Agents Chemother VL - 59 ID - Tumwebaze2015 ER - TY - JOUR AU - Malmberg, M. AU - Ferreira, P. E. AU - Tarning, J. AU - Ursing, J. AU - Ngasala, B. AU - Bjorkman, A. PY - 2012 DA - 2012// TI - Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms JO - J Infect Dis VL - 207 ID - Malmberg2012 ER - TY - JOUR AU - Mbaye, A. AU - Dieye, B. AU - Ndiaye, Y. D. AU - Bei, A. K. AU - Muna, A. AU - Deme, A. B. PY - 2016 DA - 2016// TI - Selection of N86F184D1246 haplotype of Pfmrd1 gene by Artemether−lumefantrine drug pressure on Plasmodium falciparum populations in Senegal JO - Malar J. VL - 15 ID - Mbaye2016 ER - TY - JOUR AU - Djimde, A. AU - Doumbo, O. K. AU - Cortese, J. F. AU - Kayentao, K. AU - Doumbo, S. AU - Diourte, Y. PY - 2001 DA - 2001// TI - A molecular marker for chloroquine-resistant falciparum malaria JO - N Engl J Med VL - 344 ID - Djimde2001 ER - TY - JOUR AU - Wellems, T. E. AU - Plowe, C. V. PY - 2001 DA - 2001// TI - Chloroquine-resistant malaria JO - J Infect Dis VL - 184 ID - Wellems2001 ER - TY - JOUR AU - Witkowski, B. AU - Duru, V. AU - Khim, N. AU - Ross, L. S. AU - Saintpierre, B. AU - Beghain, J. PY - 2017 DA - 2017// TI - A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study JO - Lancet Infect Dis. VL - 17 ID - Witkowski2017 ER - TY - JOUR AU - Ariey, F. AU - Witkowski, B. AU - Amaratunga, C. AU - Beghain, J. AU - Langlois, A. C. AU - Khim, N. PY - 2014 DA - 2014// TI - A molecular marker of artemisinin-resistant Plasmodium falciparum malaria JO - Nature VL - 505 ID - Ariey2014 ER - TY - JOUR AU - Straimer, J. AU - Gnadig, N. F. AU - Witkowski, B. AU - Amaratunga, C. AU - Duru, V. AU - Ramadani, A. P. PY - 2015 DA - 2015// TI - Drug resistance K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates JO - Science. VL - 347 ID - Straimer2015 ER - TY - JOUR AU - Dokomajilar, C. AU - Nsobya, S. L. AU - Greenhouse, B. AU - Rosenthal, P. J. AU - Dorsey, G. PY - 2006 DA - 2006// TI - Selection of Plasmodium falciparum pfmdr1 alleles following therapy with Artemether−lumefantrine in an area of Uganda where malaria is highly endemic JO - Antimicrob Agents Chemother VL - 50 ID - Dokomajilar2006 ER - TY - JOUR AU - Happi, C. T. AU - Gbotosho, G. O. AU - Folarin, O. A. AU - Sowunmi, A. AU - Hudson, T. AU - O’Neil, M. PY - 2009 DA - 2009// TI - Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by Artemether−lumefantrine in Nigerian children with uncomplicated falciparum malaria JO - Antimicrob Agents Chemother VL - 53 ID - Happi2009 ER - TY - JOUR AU - Humphreys, G. S. AU - Merinopoulos, I. AU - Ahmed, J. AU - Whitty, C. J. AU - Mutabingwa, T. K. AU - Sutherland, C. J. PY - 2007 DA - 2007// TI - Amodiaquine and Artemether−lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria JO - Antimicrob Agents Chemother VL - 51 ID - Humphreys2007 ER - TY - JOUR AU - Sisowath, C. AU - Stromberg, J. AU - Martensson, A. AU - Msellem, M. AU - Obondo, C. AU - Bjorkman, A. PY - 2005 DA - 2005// TI - In vivo selection of Plasmodium falciparum pfmdr1 86 N coding alleles by Artemether−lumefantrine (Coartem) JO - J Infect Dis VL - 191 ID - Sisowath2005 ER - TY - JOUR AU - Zongo, I. AU - Dorsey, G. AU - Rouamba, N. AU - Tinto, H. AU - Dokomajilar, C. AU - Guiguemde, R. T. PY - 2007 DA - 2007// TI - Artemether−lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial JO - Lancet VL - 369 ID - Zongo2007 ER - TY - JOUR AU - Imwong, M. AU - Suwannasin, K. AU - Kunasol, C. AU - Sutawong, K. AU - Mayxay, M. AU - Rekol, H. PY - 2017 DA - 2017// TI - The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study JO - Lancet Infect Dis. VL - 17 ID - Imwong2017 ER - TY - JOUR AU - Achieng, A. O. AU - Muiruri, P. AU - Ingasia, L. A. AU - Opot, B. H. AU - Juma, D. W. AU - Yeda, R. PY - 2015 DA - 2015// TI - Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by Artemether−lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya JO - Int J Parasitol Drugs Drug Resist. VL - 5 ID - Achieng2015 ER - TY - JOUR AU - Hemming-Schroeder, E. AU - Umukoro, E. AU - Lo, E. AU - Fung, B. AU - Tomas-Domingo, P. AU - Zhou, G. PY - 2018 DA - 2018// TI - Impacts of antimalarial drugs on Plasmodium falciparum drug resistance markers, Western Kenya, 2003-2015 JO - Am J Trop Med Hyg VL - 98 ID - Hemming-Schroeder2018 ER - TY - JOUR AU - Kamau, E. AU - Campino, S. AU - Amenga-Etego, L. AU - Drury, E. AU - Ishengoma, D. AU - Johnson, K. PY - 2015 DA - 2015// TI - K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa JO - J Infect Dis VL - 211 ID - Kamau2015 ER - TY - JOUR AU - Wongsrichanalai, C. AU - Pickard, A. L. AU - Wernsdorfer, W. H. AU - Meshnick, S. R. PY - 2002 DA - 2002// TI - Epidemiology of drug-resistant malaria JO - Lancet Infect Dis. VL - 2 ID - Wongsrichanalai2002 ER - TY - JOUR AU - Venkatesan, M. AU - Gadalla, N. B. AU - Stepniewska, K. AU - Dahal, P. AU - Nsanzabana, C. AU - Moriera, C. PY - 2014 DA - 2014// TI - Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after Artemether−lumefantrine and artesunate-amodiaquine JO - Am J Trop Med Hyg. VL - 91 ID - Venkatesan2014 ER - TY - STD TI - Westercamp N, Owidhi M, Otieno K, Chebore W, Buff A, Desai M, et al. Efficacy of Artemether−lumefantrine and Dihydroartemisinin−piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria among children in western Kenya. 2020 (In press). ID - ref32 ER - TY - BOOK PY - 2009 DA - 2009// TI - Methods for surveillance of antimalarial drug efficacy PB - World Health Organization CY - Geneva ID - ref33 ER - TY - JOUR AU - Odero, N. A. AU - Samuels, A. M. AU - Odongo, W. AU - Abong’o, B. AU - Gimnig, J. AU - Otieno, K. PY - 2019 DA - 2019// TI - Community-based intermittent mass testing and treatment for malaria in an area of high transmission intensity, western Kenya: development of study site infrastructure and lessons learned JO - Malar J. VL - 18 ID - Odero2019 ER - TY - JOUR AU - Samuels, A. M. AU - Odero, N. A. AU - Odongo, W. AU - Otieno, K. AU - Were, V. AU - Shi, Y. P. PY - 2020 DA - 2020// TI - Impact of community-based mass testing and treatment on malaria infection prevalence in a high transmission area of western Kenya: a cluster randomized controlled trial JO - Clin Infect Dis UR - https://doi.org/10.1093/cid/ciaa471 DO - 10.1093/cid/ciaa471 ID - Samuels2020 ER - TY - JOUR AU - Agarwal, A. AU - McMorrow, M. AU - Onyango, P. AU - Otieno, K. AU - Odero, C. AU - Williamson, J. PY - 2013 DA - 2013// TI - A randomized trial of Artemether−lumefantrine and Dihydroartemisinin−piperaquine in the treatment of uncomplicated malaria among children in western Kenya JO - Malar J. VL - 12 ID - Agarwal2013 ER - TY - JOUR AU - Mens, P. F. AU - Sawa, P. AU - Amsterdam, S. M. AU - Versteeg, I. AU - Omar, S. A. AU - Schallig, H. D. PY - 2008 DA - 2008// TI - A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of Artemether−lumefantrine versus Dihydroartemisinin−piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya JO - Malar J. VL - 7 ID - Mens2008 ER - TY - JOUR AU - Sawa, P. AU - Shekalaghe, S. A. AU - Drakeley, C. J. AU - Sutherland, C. J. AU - Mweresa, C. K. AU - Baidjoe, A. Y. PY - 2013 DA - 2013// TI - Malaria transmission after Artemether−lumefantrine and Dihydroartemisinin−piperaquine: a randomized trial JO - J Infect Dis VL - 207 ID - Sawa2013 ER - TY - JOUR AU - Woodring, J. V. AU - Ogutu, B. AU - Schnabel, D. AU - Waitumbi, J. N. AU - Olsen, C. H. AU - Walsh, D. S. PY - 2010 DA - 2010// TI - Evaluation of recurrent parasitemia after Artemether−lumefantrine treatment for uncomplicated malaria in children in western Kenya JO - Am J Trop Med Hyg VL - 83 ID - Woodring2010 ER - TY - BOOK PY - 2008 DA - 2008// TI - Recommended Genotyping Procedures (RGPs) to identify parasite populations PB - World Health Organization CY - Geneva ID - ref40 ER - TY - JOUR AU - Souza, S. S. AU - L’Episcopia, M. AU - Severini, C. AU - Udhayakumar, V. AU - Lucchi, N. W. PY - 2018 DA - 2018// TI - Photo-induced electron transfer real-time PCR for detection of Plasmodium falciparum plasmepsin 2 gene copy number JO - Antimicrob Agents Chemother VL - 62 ID - Souza2018 ER - TY - JOUR AU - Talundzic, E. AU - Chenet, S. M. AU - Goldman, I. F. AU - Patel, D. S. AU - Nelson, J. A. AU - Plucinski, M. M. PY - 2015 DA - 2015// TI - Genetic analysis and species specific amplification of the artemisinin resistance-associated Kelch Propeller domain in P. falciparum and P. vivax JO - PLoS One. VL - 10 ID - Talundzic2015 ER - TY - JOUR AU - Griffing, S. AU - Syphard, L. AU - Sridaran, S. AU - McCollum, A. M. AU - Mixson-Hayden, T. AU - Vinayak, S. PY - 2010 DA - 2010// TI - pfmdr1 amplification and fixation of pfcrt chloroquine resistance alleles in Plasmodium falciparum in Venezuela JO - Antimicrob Agents Chemother VL - 54 ID - Griffing2010 ER - TY - JOUR AU - Vinayak, S. AU - Alam, M. T. AU - Sem, R. AU - Shah, N. K. AU - Susanti, A. I. AU - Lim, P. PY - 2010 DA - 2010// TI - Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in Cambodia JO - J Infect Dis VL - 201 ID - Vinayak2010 ER - TY - JOUR AU - Mejia Torres, R. E. AU - Banegas, E. I. AU - Mendoza, M. AU - Diaz, C. AU - Bucheli, S. T. AU - Fontecha, G. A. PY - 2013 DA - 2013// TI - Efficacy of chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in Honduras JO - Am J Trop Med Hyg VL - 88 ID - Mejia Torres2013 ER - TY - JOUR AU - Ljolje, D. AU - Dimbu, P. R. AU - Kelley, J. AU - Goldman, I. AU - Nace, D. AU - Macaia, A. PY - 2018 DA - 2018// TI - Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015 JO - Malar J. VL - 17 ID - Ljolje2018 ER - TY - JOUR AU - Nosten, F. AU - White, N. J. PY - 2007 DA - 2007// TI - Artemisinin-based combination treatment of falciparum malaria JO - Am J Trop Med Hyg VL - 77 ID - Nosten2007 ER - TY - JOUR AU - Muwanguzi, J. AU - Henriques, G. AU - Sawa, P. AU - Bousema, T. AU - Sutherland, C. J. AU - Beshir, K. B. PY - 2016 DA - 2016// TI - Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children JO - Malar J. VL - 15 ID - Muwanguzi2016 ER - TY - STD TI - Wamae K, Okanda D, Ndwiga L, Osoti V, Kimenyi KM, Abdi AI, et al. No evidence of P. falciparum K13 artemisinin conferring mutations over a 24-year analysis in Coastal Kenya, but a near complete reversion to chloroquine wild type parasites. Antimicrob Agents Chemother. 2019;e01067-19. ID - ref49 ER - TY - JOUR AU - Nguetse, C. N. AU - Adegnika, A. A. AU - Agbenyega, T. AU - Ogutu, B. R. AU - Krishna, S. AU - Kremsner, P. G. PY - 2017 DA - 2017// TI - Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria JO - Malar J. VL - 16 ID - Nguetse2017 ER - TY - JOUR AU - Ashley, E. A. AU - Dhorda, M. AU - Fairhurst, R. M. AU - Amaratunga, C. AU - Lim, P. AU - Suon, S. PY - 2014 DA - 2014// TI - Spread of artemisinin resistance in Plasmodium falciparum malaria JO - N Engl J Med VL - 371 ID - Ashley2014 ER - TY - JOUR AU - Kaur, H. AU - Clarke, S. AU - Lalani, M. AU - Phanouvong, S. AU - Guerin, P. AU - McLoughlin, A. PY - 2016 DA - 2016// TI - Fake anti-malarials: start with the facts JO - Malar J. VL - 15 ID - Kaur2016 ER - TY - JOUR AU - Dokomajilar, C. AU - Lankoande, Z. M. AU - Dorsey, G. AU - Zongo, I. AU - Ouedraogo, J. B. AU - Rosenthal, P. J. PY - 2006 DA - 2006// TI - Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso JO - Am J Trop Med Hyg VL - 75 ID - Dokomajilar2006 ER - TY - JOUR AU - Some, A. F. AU - Zongo, I. AU - Compaore, Y. D. AU - Sakande, S. AU - Nosten, F. AU - Ouedraogo, J. B. PY - 2014 DA - 2014// TI - Selection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina Faso JO - Antimicrob Agents Chemother VL - 58 ID - Some2014 ER - TY - JOUR AU - Hastings, I. M. AU - Ward, S. A. PY - 2005 DA - 2005// TI - Coartem (Artemether−lumefantrine) in Africa: the beginning of the end? JO - J Infect Dis VL - 192 ID - Hastings2005 ER - TY - JOUR AU - Wurtz, N. AU - Fall, B. AU - Pascual, A. AU - Fall, M. AU - Baret, E. AU - Camara, C. PY - 2014 DA - 2014// TI - Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin JO - Antimicrob Agents Chemother VL - 58 ID - Wurtz2014 ER - TY - JOUR AU - Taylor, A. R. AU - Flegg, J. A. AU - Holmes, C. C. AU - Guerin, P. J. AU - Sibley, C. H. AU - Conrad, M. D. PY - 2017 DA - 2017// TI - Artemether−lumefantrine and Dihydroartemisinin−piperaquine exert inverse selective pressure on Plasmodium falciparum drug sensitivity-associated haplotypes in Uganda JO - Open Forum Infect Dis. VL - 4 ID - Taylor2017 ER - TY - JOUR AU - Lucchi, N. W. AU - Komino, F. AU - Okoth, S. A. AU - Goldman, I. AU - Onyona, P. AU - Wiegand, R. E. PY - 2015 DA - 2015// TI - In vitro and molecular surveillance for antimalarial drug resistance in Plasmodium falciparum parasites in Western Kenya reveals sustained artemisinin sensitivity and increased chloroquine sensitivity JO - Antimicrob Agents Chemother VL - 59 ID - Lucchi2015 ER - TY - JOUR AU - Kublin, J. G. AU - Cortese, J. F. AU - Njunju, E. M. AU - Mukadam, R. A. AU - Wirima, J. J. AU - Kazembe, P. N. PY - 2003 DA - 2003// TI - Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi JO - J Infect Dis VL - 187 ID - Kublin2003 ER - TY - JOUR AU - Dagnogo, O. AU - Ako, A. B. AU - Ouattara, L. AU - Dago, N. D. AU - Coulibaly, D. N. AU - Toure, A. O. PY - 2018 DA - 2018// TI - Towards a re-emergence of chloroquine sensitivity in Cote d’Ivoire? JO - Malar J. VL - 17 ID - Dagnogo2018 ER - TY - JOUR AU - Callaghan, P. S. AU - Siriwardana, A. AU - Hassett, M. R. AU - Roepe, P. D. PY - 2016 DA - 2016// TI - Plasmodium falciparum chloroquine resistance transporter (PfCRT) isoforms PH1 and PH2 perturb vacuolar physiology JO - Malar J. VL - 15 ID - Callaghan2016 ER - TY - JOUR AU - Awasthi, G. AU - Das, A. PY - 2013 DA - 2013// TI - Genetics of chloroquine-resistant malaria: a haplotypic view JO - Mem Inst Oswaldo Cruz VL - 108 ID - Awasthi2013 ER - TY - JOUR AU - Callaghan, P. S. AU - Hassett, M. R. AU - Roepe, P. D. PY - 2015 DA - 2015// TI - Functional comparison of 45 naturally occurring isoforms of the Plasmodium falciparum chloroquine resistance transporter (PfCRT) JO - Biochemistry VL - 54 ID - Callaghan2015 ER -